BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15701852)

  • 1. Gene expression in kidney cancer is associated with cytogenetic abnormalities, metastasis formation, and patient survival.
    Sültmann H; von Heydebreck A; Huber W; Kuner R; Buness A; Vogt M; Gunawan B; Vingron M; Füzesí L; Poustka A
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):646-55. PubMed ID: 15701852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene signatures of progression and metastasis in renal cell cancer.
    Jones J; Otu H; Spentzos D; Kolia S; Inan M; Beecken WD; Fellbaum C; Gu X; Joseph M; Pantuck AJ; Jonas D; Libermann TA
    Clin Cancer Res; 2005 Aug; 11(16):5730-9. PubMed ID: 16115910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential gene expression identifies subgroups of renal cell carcinoma.
    Skubitz KM; Zimmermann W; Kammerer R; Pambuccian S; Skubitz AP
    J Lab Clin Med; 2006 May; 147(5):250-67. PubMed ID: 16697773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiling predicts survival in conventional renal cell carcinoma.
    Zhao H; Ljungberg B; Grankvist K; Rasmuson T; Tibshirani R; Brooks JD
    PLoS Med; 2006 Jan; 3(1):e13. PubMed ID: 16318415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profiling of renal cell carcinoma and clinical implications.
    Rogers CG; Tan MH; Teh BT
    Urology; 2005 Feb; 65(2):231-7. PubMed ID: 15708028
    [No Abstract]   [Full Text] [Related]  

  • 6. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
    Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
    Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.
    Minervini A; Di Cristofano C; Gacci M; Serni S; Menicagli M; Lanciotti M; Salinitri G; Rocca CD; Lapini A; Nesi G; Bevilacqua G; Minervini R; Carini M
    J Urol; 2008 Oct; 180(4):1284-9. PubMed ID: 18707725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and gene expression analysis of novel matched primary and metastatic renal cell carcinoma cell lines.
    Ohno Y; Izumi M; Tachibana M; Kawamura T; Yoshioka K; Aoyagi T; Ohori M; Namiki K; Sakamoto N; Nakagami Y; Hatano T; Akimoto S; Nishimura T
    Oncol Rep; 2008 Sep; 20(3):501-9. PubMed ID: 18695898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal translocation carcinomas: clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature.
    Camparo P; Vasiliu V; Molinie V; Couturier J; Dykema KJ; Petillo D; Furge KA; Comperat EM; Lae M; Bouvier R; Boccon-Gibod L; Denoux Y; Ferlicot S; Forest E; Fromont G; Hintzy MC; Laghouati M; Sibony M; Tucker ML; Weber N; Teh BT; Vieillefond A
    Am J Surg Pathol; 2008 May; 32(5):656-70. PubMed ID: 18344867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tubulocystic carcinoma of the kidney: clinicopathologic and molecular characterization.
    Yang XJ; Zhou M; Hes O; Shen S; Li R; Lopez J; Shah RB; Yang Y; Chuang ST; Lin F; Tretiakova MM; Kort EJ; Teh BT
    Am J Surg Pathol; 2008 Feb; 32(2):177-87. PubMed ID: 18223319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-resolution analysis of DNA copy number alterations and gene expression in renal clear cell carcinoma.
    Yoshimoto T; Matsuura K; Karnan S; Tagawa H; Nakada C; Tanigawa M; Tsukamoto Y; Uchida T; Kashima K; Akizuki S; Takeuchi I; Sato F; Mimata H; Seto M; Moriyama M
    J Pathol; 2007 Dec; 213(4):392-401. PubMed ID: 17922474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide gene expression profiles of clear cell renal cell carcinoma: identification of molecular targets for treatment of renal cell carcinoma.
    Hirota E; Yan L; Tsunoda T; Ashida S; Fujime M; Shuin T; Miki T; Nakamura Y; Katagiri T
    Int J Oncol; 2006 Oct; 29(4):799-827. PubMed ID: 16964377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional profiles in peripheral blood mononuclear cells prognostic of clinical outcomes in patients with advanced renal cell carcinoma.
    Burczynski ME; Twine NC; Dukart G; Marshall B; Hidalgo M; Stadler WM; Logan T; Dutcher J; Hudes G; Trepicchio WL; Strahs A; Immermann F; Slonim DK; Dorner AJ
    Clin Cancer Res; 2005 Feb; 11(3):1181-9. PubMed ID: 15709187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiling of renal medullary carcinoma: potential clinical relevance.
    Yang XJ; Sugimura J; Tretiakova MS; Furge K; Zagaja G; Sokoloff M; Pins M; Bergan R; Grignon DJ; Stadler WM; Vogelzang NJ; Teh BT
    Cancer; 2004 Mar; 100(5):976-85. PubMed ID: 14983493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A molecular classification of papillary renal cell carcinoma.
    Yang XJ; Tan MH; Kim HL; Ditlev JA; Betten MW; Png CE; Kort EJ; Futami K; Furge KA; Takahashi M; Kanayama HO; Tan PH; Teh BS; Luan C; Wang K; Pins M; Tretiakova M; Anema J; Kahnoski R; Nicol T; Stadler W; Vogelzang NG; Amato R; Seligson D; Figlin R; Belldegrun A; Rogers CG; Teh BT
    Cancer Res; 2005 Jul; 65(13):5628-37. PubMed ID: 15994935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness.
    Kosari F; Parker AS; Kube DM; Lohse CM; Leibovich BC; Blute ML; Cheville JC; Vasmatzis G
    Clin Cancer Res; 2005 Jul; 11(14):5128-39. PubMed ID: 16033827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of gene signatures for invasive colorectal tumor cells.
    Wiese AH; Auer J; Lassmann S; Nährig J; Rosenberg R; Höfler H; Rüger R; Werner M
    Cancer Detect Prev; 2007; 31(4):282-95. PubMed ID: 17936523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological significance of c-met over expression in papillary renal cell carcinoma.
    Sweeney P; El-Naggar AK; Lin SH; Pisters LL
    J Urol; 2002 Jul; 168(1):51-5. PubMed ID: 12050491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcription profiling of renal cell carcinoma.
    Huber W; Boer JM; von Heydebreck A; Gunawan B; Vingron M; Füzesi L; Poustka A; Sültmann H
    Verh Dtsch Ges Pathol; 2002; 86():153-64. PubMed ID: 12647365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of the human stem cell marker, Rex-1 (zfp-42), in renal cell carcinoma.
    Raman JD; Mongan NP; Liu L; Tickoo SK; Nanus DM; Scherr DS; Gudas LJ
    Carcinogenesis; 2006 Mar; 27(3):499-507. PubMed ID: 16344273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.